[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Panbela Therapeutics Inc (PBLA)

Panbela Therapeutics Inc (PBLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])

Fundamentals

See More
  • Market Capitalization, $K 54
  • Shares Outstanding, K 4,855
  • Annual Sales, $ 0 K
  • Annual Income, $ -25,260 K
  • EBIT $ -29 M
  • EBITDA $ -29 M
  • 60-Month Beta 42.27
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -71.13
  • Most Recent Earnings N/A on 11/09/23
  • Next Earnings Date 01/01/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0002 unch
on 06/10/26
0.0111 -98.20%
on 06/04/26
-0.0008 (-80.00%)
since 05/08/26
3-Month
0.0002 unch
on 06/10/26
0.0131 -98.47%
on 04/20/26
-0.0129 (-98.47%)
since 03/03/26
52-Week
0.0001 +100.00%
on 12/31/25
0.3000 -99.93%
on 06/16/25
-0.2467 (-99.92%)
since 06/09/25

Most Recent Stories

More News
Panbela Provides Business Update and Reports Q3 2024 Financial Results

PBLA : 0.0002 (-98.20%)
Panbela to Host Third Quarter 2024 Earnings Conference Call on November 14, 2024

PBLA : 0.0002 (-98.20%)
Panbela Announces First Patient Enrolled in its Aspire Trial Studying SBP-101 in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Ductal Adenocarcinoma

Expects interim data by early 2024...

PBLA : 0.0002 (-98.20%)
Panbela Expands Aspire Trial to Australia, Studying SBP-101 in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Ductal Adenocarcinoma

MINNEAPOLIS, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics for...

PBLA : 0.0002 (-98.20%)
Panbela Schedules Conference Call on, August 15, 2022, to Report 2022 Second Quarter Financial Results

MINNEAPOLIS, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics for...

PBLA : 0.0002 (-98.20%)
50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021

RALEIGH, NC / ACCESSWIRE / July 8, 2021 / Access to Giving - an investor conference themed around investor education and advocacy begins next week, July 13th - 15th, 2021. More than 50 companies are scheduled...

TRIQ : 0.4000 (-27.27%)
DMIFF : 0.0025 (unch)
PBLA : 0.0002 (-98.20%)
THBRF : 1.2101 (-3.19%)
ATGN : 0.4750 (-3.06%)
STRR : 11.04 (-2.60%)
ADXN : 6.45 (+4.03%)
MKTY : 12.66 (-1.40%)
BTX : 9.03 (+0.89%)
FLUX : 0.8456 (-7.28%)
NMTC : 3.24 (unch)
NEPH : 3.34 (+0.30%)
50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021

RALEIGH, NC / ACCESSWIRE / June 23, 2021 / Access to Giving - an investor conference themed around investor education and advocacy is set for July 13-15, 2021. There will be 50+ companies conducting virtual...

DMIFF : 0.0025 (unch)
PBLA : 0.0002 (-98.20%)
ATGN : 0.4750 (-3.06%)
STRR : 11.04 (-2.60%)
ADXN : 6.45 (+4.03%)
MKTY : 12.66 (-1.40%)
FLUX : 0.8456 (-7.28%)
NMTC : 3.24 (unch)
NEPH : 3.34 (+0.30%)
ACER : 0.6601 (-17.95%)
BSFC : 0.0013 (+30.00%)
DTST : 3.13 (-8.21%)

Business Summary

Panbela Therapeutics Inc. is a clinical-stage biopharmaceutical company. It engages in developing disruptive therapeutics for patients with urgent unmet medical needs. The company's initial product candidate, SBP-101, is for the treatment of patients with metastatic pancreatic ductal adenocarcinoma,...

See More

Key Turning Points

3rd Resistance Point 0.0111
2nd Resistance Point 0.0111
1st Resistance Point 0.0111
Last Price 0.0002
1st Support Level 0.0111
2nd Support Level 0.0111
3rd Support Level 0.0111

See More

52-Week High 0.3000
Fibonacci 61.8% 0.1854
Fibonacci 50% 0.1500
Fibonacci 38.2% 0.1147
Last Price 0.0002
52-Week Low 0.0001

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.